Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: Time course studies

Psychopharmacology

Volumn 161, Issue 2, 2002, Pages 189-201

  Swerdlow, Neal R ^a   Eastvold, Angela ^a   Karban, Blythe ^a   Ploum, Yvonne ^b   Stephany, Nora ^a   Geyer, Mark A ^a   Cadenhead, Kristin ^a   Auerbach, Pamela P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Amantadine; Amphetamine; Bromocriptine; Pergolide; Prepulse inhibition; Schizophrenia; Startle

Indexed keywords

AMANTADINE; AMPHETAMINE; BROMOCRIPTINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; PERGOLIDE; PLACEBO;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CONTROLLED STUDY; DROWSINESS; DRUG ACTIVITY; DRUG EFFECT; HAPPINESS; HEART RATE; HUMAN; INGESTION; MALE; NORMAL HUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX; TACTILE STIMULATION;

ADOLESCENT; ADULT; AMANTADINE; AMPHETAMINE; ANALYSIS OF VARIANCE; BLOOD PRESSURE; BROMOCRIPTINE; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; HEART RATE; HUMANS; MALE; PERGOLIDE; PSYCHOMOTOR PERFORMANCE; STARTLE REACTION; TIME FACTORS;

EID: 0036255026     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1040-3     Document Type: Article

References (53)

1. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man
2. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects
3. Prepulse effects on magnitude estimation of startle-eliciting stimuli and startle responses
4. The use of analogue scales in rating subjective feelings
5. Sensorimotor gating and schizophrenia. Human and animal model studies
6. Prestimulus effects on human startle reflex in normals and schizophrenics
7. Gating and habituation of the startle reflex in schizophrenic patients
8. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients
9. Human studies of pre-pulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies
10. Structured interview for assessing perceptual anomalies (SIAPA)
11. Impaired startle prepulse inhibition and habituation in schizotypal patients
12. Modulation of the startle response and startle laterality in relatives of schizophrenia patients and schizotypal personality disordered subjects: Evidence of inhibitory deficits
13. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation
14. The tridimensional personality questionnaire: US normative data
15. Gastrointestinal decontamination in the management of the poisoned patient
16. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
17. Clinical and sensorimotor gating effects of ketamine in normals
18. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review
19. Startle gating deficits occur across prepulse intensities in schizophrenic patients
20. The more or less startling effects of weak pre-stimuli
21. Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans
22. Personality factors moderate subjective and psychophysiological responses to d-amphetamine in humans
23. Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque
24. Blink rates and disorders of movement
25. Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry
26. Effects of the 1-amino-adamantanes at the MK-801 binding site of the NMDA-receptor-gated ion channel: A human postmortem brain study
27. Effects of single oral administrations of haloperidol and d-amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers
28. Normalization of information processing deficits in schizophrenia with clozapine
29. Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys
30. Dopaminergic stimulation disrupts sensorimotor gating in the rat
31. PHNO, a selective D2 receptor agonist, does not reduce prepulse inhibition of the startle reflex in rats
32. The action of sedation on brain-stem oculomotor systems in man
33. Comparison of the potency, kinetics and voltage-dependency of open channel blockade for a series of uncompetitive NMDA antagonists in vitro with anticonvulsive and motor impairment activity in vivo
34. Time order error in successive judgments and in reflexes. I. Inhibition of the judgment and the reflex
35. Pergolide mesylate: Its effects on circulating anterior pituitary hormones in man
36. Cortico-striatal substrates of cognitive, motor and sensory gating: Speculations and implications for psychological function and dysfunction
37. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia
38. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients
39. Impaired prepulse inhibition of acoustic and tactile startle in patients with Huntington's disease
40. Changes in sensorimotor inhibition across the menstrual cycle: Implications for neuropsychiatric disorders
41. Towards a cross-species pharmacology of sensorimotor gating: Effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats
42. Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: Impact of caffeine intake and withdrawal
43. Neural circuitry of prepulse inhibition of startle in the rat: Current knowledge and future challenges
44. Matching strategies for drug studies of prepulse inhibition in humans
45. Effects of pergolide on sensorimotor gating of the startle reflex in rats
46. Effects of amantadine on startle gating in normal male humans and rats
47. Prestimulus modification of the startle reflex: Relationship to personality and physiological markers of dopamine function
48. Inhibitory effect of MK-801 on amantadine-induced dopamine release in the rat striatum
49. Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans
50. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation
51. Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients